1887

Journal of General Virology header logo

Volume 84, Issue 6

The latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus interacts preferentially with the terminal repeats of the genome and this complex is sufficient for episomal DNA replication Free

Abstract

The genome of Kaposi's sarcoma-associated herpesvirus (KSHV) persists in latently infected cells as a circular episome. The latency-associated nuclear antigen (LANA) has been shown to tether viral DNA fragments to chromosomes and is proposed to maintain the KSHV genome. In order to identify the -binding sites for LANA on the whole KSHV genome and to analyse the function of this protein–DNA interaction, different systems have been developed. Chromatin immunoprecipitation experiments using three different cell lines latently infected with KSHV demonstrated that LANA binds preferentially and directly to the terminal repeats (TRs) but not to other regions of the viral chromosome . In contrast, LANA–DNA binding was much less specific. To identify autonomously replicating sequences within the KSHV genome, BCBL-1 cells were transfected with cosmids representing the entire genome. Cosmid Z2, consisting of the right end of the unique region and TRs, persisted as an episome in short-term assays. Long term, stable episome replication was observed with constructs derived from Z2 containing TRs only. LANA expression constructs containing a variable number of TRs replicated stably as episomes in uninfected cells. A 424 bp subfragment of the 801 bp TR could mediate episome replication. These studies show that LANA is a -acting protein that binds preferentially to TRs and these two elements are sufficient for episome replication. These results also suggest that the LANA expression plasmids reported here could be utilized as episomal vectors in a manner similar to Epstein–Barr virus-based vectors.

  • Received:
  • Accepted:
  • Published Online:
SGM
Loading

Article metrics loading...

/content/journal/jgv/10.1099/vir.0.18940-0
2003-06-01
2024-04-18
Loading full text...

Full text loading...

/deliver/fulltext/jgv/84/6/vir841451.html?itemId=/content/journal/jgv/10.1099/vir.0.18940-0&mimeType=html&fmt=ahah

References

  1. Ausubel M. F., Brent R., Kingston R. E., Moore D. D., Seidman J. G., Smith J. A., Struhl K. 1995 Current Protocols in Molecular Biology New York: John Wiley & Sons;
     [Google Scholar]
  2. Ballestas M. E., Kaye K. M. 2001; Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen 1 mediates episome persistence through cis -acting terminal repeat (TR) sequence and specifically binds TR DNA. J Virol 75:3250–3258
     [Google Scholar]
  3. Ballestas M. E., Chatis P. A., Kaye K. M. 1999; Efficient persistence of extrachromosomal KSHV DNA mediated by latency-associated nuclear antigen. Science 284:641–644
     [Google Scholar]
  4. Bayle J. H., Elenbaas B., Levine A. J. 1995; The carboxyl-terminal domain of the p53 protein regulates sequence-specific DNA binding through its nonspecific nucleic acid-binding activity. Proc Natl Acad Sci U S A 92:5729–5733
     [Google Scholar]
  5. Cesarman E., Chang Y., Moore P. S., Said J. W., Knowles D. M. 1995a; Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas. N Engl J Med 332:1186–1191
     [Google Scholar]
  6. Cesarman E., Moore P. S., Rao P. H., Inghirami G., Knowles D. M., Chang Y. 1995b; In vitro establishment and characterization of two acquired immunodeficiency syndrome-related lymphoma cell lines (BC-1 and BC-2) containing Kaposi's sarcoma-associated herpesvirus-like (KSHV) DNA sequences. Blood 86:2708–2714
     [Google Scholar]
  7. Challberg M. D., Kelly T. J. 1989; Animal virus DNA replication. Annu Rev Biochem 58:671–717
     [Google Scholar]
  8. Chang Y., Cesarman E., Pessin M. S., Lee F., Culpepper J., Knowles D. M., Moore P. S. 1994; Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 266:1865–1869
     [Google Scholar]
  9. Chittenden T., Lupton S., Levine A. J. 1989; Functional limits of oriP, the Epstein–Barr virus plasmid origin of replication. J Virol 63:3016–3025
     [Google Scholar]
  10. Collins C. M., Medveczky M. M., Lund T., Medveczky P. G. 2002; The terminal repeats and latency-associated nuclear antigen of herpesvirus saimiri are essential for episomal persistence of the viral genome. J Gen Virol 83:2269–2278
     [Google Scholar]
  11. Cotter M. A. II, Robertson E. S. 1999; The latency-associated nuclear antigen tethers the Kaposi's sarcoma-associated herpesvirus genome to host chromosomes in body cavity-based lymphoma cells. Virology 264:254–264
     [Google Scholar]
  12. Friborg J. Jr, Kong W., Hottiger M. O., Nabel G. J. 1999; p53 inhibition by the LANA protein of KSHV protects against cell death. Nature 402:889–894
     [Google Scholar]
  13. Garber A. C., Shu M. A., Hu J., Renne R. 2001; DNA binding and modulation of gene expression by the latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus. J Virol 75:7882–7892
     [Google Scholar]
  14. Gardella T., Medveczky P., Sairenji T., Mulder C. 1984; Detection of circular and linear herpesvirus DNA molecules in mammalian cells by gel electrophoresis. J Virol 50:248–254
     [Google Scholar]
  15. Gilmour D. S., Rougvie A. E., Lis J. T. 1991; Protein–DNA cross-linking as a means to determine the distribution of proteins on DNA in vivo . Methods Cell Biol 35:369–381
     [Google Scholar]
  16. Hirt B. 1967; Selective extraction of polyoma DNA from infected mouse cell cultures. J Mol Biol 26:365–369
     [Google Scholar]
  17. Kedes D. H., Lagunoff M., Renne R., Ganem D. 1997; Identification of the gene encoding the major latency-associated nuclear antigen of the Kaposi's sarcoma-associated herpesvirus. J Clin Invest 100:2606–2610
     [Google Scholar]
  18. Krithivas A., Young D. B., Liao G., Greene D., Hayward S. D. 2000; Human herpesvirus 8 LANA interacts with proteins of the mSin3 corepressor complex and negatively regulates Epstein–Barr virus gene expression in dually infected PEL cells. J Virol 74:9637–9645
     [Google Scholar]
  19. Lim C., Gwack Y., Hwang S., Kim S., Choe J. 2001; The transcriptional activity of cAMP response element-binding protein-binding protein is modulated by the latency associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus. J Biol Chem 276:31016–31022
     [Google Scholar]
  20. Lim C., Sohn H., Lee D., Gwack Y., Choe J. 2002; Functional dissection of latency-associated nuclear antigen 1 of Kaposi's sarcoma-associated herpesvirus involved in latent DNA replication and transcription of terminal repeats of the viral genome. J Virol 76:10320–10331
     [Google Scholar]
  21. Lund T., Medveczky M. M., Medveczky P. G. 1997; Herpesvirus saimiri Tip-484 membrane protein markedly increases p56lck activity in T cells. J Virol 71:378–382
     [Google Scholar]
  22. Medveczky M. M., Geck P., Vassallo R., Medveczky P. G. 1993; Expression of the collagen-like putative oncoprotein of herpesvirus saimiri in transformed T cells. Virus Genes 7:349–365
     [Google Scholar]
  23. Moore P. S., Gao S. J., Dominguez G. 7 other authors 1996; Primary characterization of a herpesvirus agent associated with Kaposi's sarcomae. J Virol 70:549–558
     [Google Scholar]
  24. Orlando V. 2000; Mapping chromosomal proteins in vivo by formaldehyde-crosslinked-chromatin immunoprecipitation. Trends Biochem Sci 25:99–104
     [Google Scholar]
  25. Orlando V., Strutt H., Paro R. 1997; Analysis of chromatin structure by in vivo formaldehyde cross-linking. Methods 11:205–214
     [Google Scholar]
  26. Platt G. M., Simpson G. R., Mittnacht S., Schulz T. F. 1999; Latent nuclear antigen of Kaposi's sarcoma-associated herpesvirus interacts with RING3, a homolog of the Drosophila female sterile homeotic ( fsh ) gene. J Virol 73:9789–9795
     [Google Scholar]
  27. Radkov S. A., Kellam P., Boshoff C. 2000; The latent nuclear antigen of Kaposi sarcoma-associated herpesvirus targets the retinoblastoma-E2F pathway and with oncogene Hras transforms primary rat cells. Nat Med 6:1121–1127
     [Google Scholar]
  28. Rainbow L., Platt G. M., Simpson G. R., Sarid R., Gao S. J., Stoiber H., Herrington C. S., Moore P. S., Schulz T. F. 1997; The 222- to 234-kilodalton latent nuclear protein (LNA) of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) is encoded by orf73 and is a component of the latency-associated nuclear antigen. J Virol 71:5915–5921
     [Google Scholar]
  29. Reisman D., Yates J., Sugden B. 1985; A putative origin of replication of plasmids derived from Epstein–Barr virus is composed of two cis -acting components. Mol Cell Biol 5:1822–1832
     [Google Scholar]
  30. Renne R., Lagunoff M., Zhong W., Ganem D. 1996a; The size and conformation of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) DNA in infected cells and virions. J Virol 70:8151–8154
     [Google Scholar]
  31. Renne R., Zhong W., Herdnier B., McGrath M., Abbey N., Kedes D., Ganem D. 1996b; Lytic growth of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) in culture. Nat Med 2:342–346
     [Google Scholar]
  32. Russo J. J., Bohenzky R. A., Chien M.-C. 8 other authors 1996; Nucleotide sequence of the Kaposi sarcoma-associated herpesvirus (HHV8. Proc Natl Acad Sci U S A 93:14862–14867
     [Google Scholar]
  33. Schwam D. R., Luciano R. L., Mahajan S. S., Wong L., Wilson A. C. 2000; Carboxy terminus of human herpesvirus 8 latency-associated nuclear antigen mediates dimerization, transcriptional repression, and targeting to nuclear bodies. J Virol 74:8532–8540
     [Google Scholar]
  34. Sugden B., Marsh K., Yates J. 1985; A vector that replicates as a plasmid and can be efficiently selected in B-lymphoblasts transformed by Epstein–Barr virus. Mol Cell Biol 5:410–413
     [Google Scholar]
  35. Wysokenski D. A., Yates J. L. 1989; Multiple EBNA1-binding sites are required to form an EBNA1-dependent enhancer and to activate a minimal replicative origin within oriP of Epstein–Barr virus. J Virol 63:2657–2666
     [Google Scholar]
  36. Yates J., Warren N., Reisman D., Sugden B. 1984; A cis -acting element from the Epstein–Barr viral genome that permits stable replication of recombinant plasmids in latently infected cells. Proc Natl Acad Sci U S A 81:3806–3810
     [Google Scholar]
  37. Yates J. L., Warren N., Sugden B. 1985; Stable replication of plasmids derived from Epstein–Barr virus in various mammalian cells. Nature 313:812–815
     [Google Scholar]
  38. Zhu L., Wang R., Sweat A., Goldstein E., Horvat R., Chandran B. 1999; Comparison of human sera reactivities in immunoblots with recombinant human herpesvirus (HHV)-8 proteins associated with the latent (ORF73) and lytic (ORFs 65, K8·1A, and K8·1B) replicative cycles and in immunofluorescence assays with HHV-8-infected BCBL-1 cells. Virology 256:381–392
     [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/vir.0.18940-0
Loading
The latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus interacts preferentially with the terminal repeats of the genome in vivo and this complex is sufficient for episomal DNA replication
J. Gen. Virol. 84, 1451 (2003); https://doi.org/10.1099/vir.0.18940-0
/content/journal/jgv/10.1099/vir.0.18940-0
/content/journal/jgv/10.1099/vir.0.18940-0
Loading

Data & Media loading...

Most cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error